Newly Diagnosed Mantle Cell Lymphoma
2 clinical trials · Condition
◉ Watch Newly Diagnosed Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma (NCT05506410) | Zhengzhou University | 2022-08-12 |
| Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL (NCT04624958) | Sun Yat-sen University | 2020-12-01 |
Track Newly Diagnosed Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.